Original language | English |
---|---|
Journal | British Journal of Cancer |
DOIs | |
Publication status | Published - 11 Sept 2020 |
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer
M.K. Greene, T. Chen, E. Robinson, N.L. Straubinger, C. Minx, D.K.W. Chan, J. Wang, J.F. Burrows, S. Van Schaeybroeck, J.R. Baker, S. Caddick, D.B. Longley, D.E. Mager, R.M. Straubinger, V. Chudasama, C.J. Scott
Research output: Contribution to journal › Article › peer-review
17
Citations
(Scopus)
174
Downloads
(Pure)